Welcome!

News Feed Item

Migraine Global Clinical Trials Review, H2, 2013

NEW YORK, Oct. 23, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Migraine Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0681715/Migraine-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

Migraine Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, "Migraine Global Clinical Trials Review, H2, 2013" provides data on the Migraine clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Migraine. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Migraine. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Migraine 6
Report Guidance 6

Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Migraine 23
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Migraine Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33

Merck & Co., Inc. 33
Clinical Trial Overview of Merck & Co., Inc. 33
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
Johnson & Johnson 39
Clinical Trial Overview of Johnson & Johnson 39
Allergan, Inc. 42
Clinical Trial Overview of Allergan, Inc. 42
AstraZeneca PLC 44
Clinical Trial Overview of AstraZeneca PLC 44
Pfizer Inc. 46
Clinical Trial Overview of Pfizer Inc. 46
Banyan Group, Inc. 48
Clinical Trial Overview of Banyan Group, Inc. 48
NuPathe Inc. 49
Clinical Trial Overview of NuPathe Inc. 49
Endo Health Solutions Inc. 50
Clinical Trial Overview of Endo Health Solutions Inc. 50

Alexza Pharmaceuticals, Inc. 51
Clinical Trial Overview of Alexza Pharmaceuticals, Inc. 51
Clinical Trial Overview of Top Institutes / Government 52
Danish Headache Center 52
Clinical Trial Overview of Danish Headache Center 52
Thomas Jefferson University 54
Clinical Trial Overview of Thomas Jefferson University 54
Montefiore Medical Center 55
Clinical Trial Overview of Montefiore Medical Center 55
Johns Hopkins University 56
Clinical Trial Overview of Johns Hopkins University 56
The Cleveland Clinic 57
Clinical Trial Overview of The Cleveland Clinic 57
Chengdu University of Traditional Chinese Medicine 58
Clinical Trial Overview of Chengdu University of Traditional Chinese Medicine 58
University of Pittsburgh 59
Clinical Trial Overview of University of Pittsburgh 59
Glostrup University Hospital 60
Clinical Trial Overview of Glostrup University Hospital 60
Shahid Beheshti University 61
Clinical Trial Overview of Shahid Beheshti University 61
Swedish Medical Center 62
Clinical Trial Overview of Swedish Medical Center 62

Five Key Clinical Profiles 63
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 112


List of Tables
Migraine Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Migraine Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Migraine Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Migraine Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Migraine Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
Migraine Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Migraine Therapeutics Clinical Trials, G7 Countries, 2013* 16
Migraine Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Migraine Therapeutics Clinical Trials, E7 Countries, 2013* 18
Migraine Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Migraine Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21

Migraine Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Migraine Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
Migraine Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24
Migraine Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25
Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Migraine Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 33
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 36
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 39
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2013* 42
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 44
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 46
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Banyan Group, Inc., 2013* 48

Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by NuPathe Inc., 2013* 49
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Health Solutions Inc., 2013* 50
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexza Pharmaceuticals, Inc., 2013* 51
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish Headache Center, 2013* 52
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2013* 54
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Montefiore Medical Center, 2013* 55
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 56
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2013* 57
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu University of Traditional Chinese Medicine, 2013* 58
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 59
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Glostrup University Hospital, 2013* 60
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University, 2013* 61
Migraine Therapeutics Clinical Trials Market, Global, Clinical Trials by Swedish Medical Center, 2013* 62

List of Figures
Migraine Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Migraine Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Migraine Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Migraine Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Migraine Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Migraine Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13
Migraine Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14
Migraine Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Migraine Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Migraine Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Migraine Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Migraine Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Migraine Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Migraine Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Migraine Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Migraine Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Migraine Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
Migraine Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Migraine Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
GlobalData Methodology 110

To order this report: Migraine Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0681715/Migraine-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy

__________________________
Contact Clare: [email protected]
US: (339)-368-6001

Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Hitrons Solutions will exhibit at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Hitrons Solutions Inc. is distributor in the North American market for unique products and services of small and medium-size businesses, including cloud services and solutions, SEO marketing platforms, and mobile applications.
In an era of historic innovation fueled by unprecedented access to data and technology, the low cost and risk of entering new markets has leveled the playing field for business. Today, any ambitious innovator can easily introduce a new application or product that can reinvent business models and transform the client experience. In their Day 2 Keynote at 19th Cloud Expo, Mercer Rowe, IBM Vice President of Strategic Alliances, and Raejeanne Skillern, Intel Vice President of Data Center Group and G...
Financial Technology has become a topic of intense interest throughout the cloud developer and enterprise IT communities. Accordingly, attendees at the upcoming 20th Cloud Expo at the Javits Center in New York, June 6-8, 2017, will find fresh new content in a new track called FinTech.
@GonzalezCarmen has been ranked the Number One Influencer and @ThingsExpo has been named the Number One Brand in the “M2M 2016: Top 100 Influencers and Brands” by Onalytica. Onalytica analyzed tweets over the last 6 months mentioning the keywords M2M OR “Machine to Machine.” They then identified the top 100 most influential brands and individuals leading the discussion on Twitter.
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
Manufacturers are embracing the Industrial Internet the same way consumers are leveraging Fitbits – to improve overall health and wellness. Both can provide consistent measurement, visibility, and suggest performance improvements customized to help reach goals. Fitbit users can view real-time data and make adjustments to increase their activity. In his session at @ThingsExpo, Mark Bernardo Professional Services Leader, Americas, at GE Digital, discussed how leveraging the Industrial Internet and...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
Web Real-Time Communication APIs have quickly revolutionized what browsers are capable of. In addition to video and audio streams, we can now bi-directionally send arbitrary data over WebRTC's PeerConnection Data Channels. With the advent of Progressive Web Apps and new hardware APIs such as WebBluetooh and WebUSB, we can finally enable users to stitch together the Internet of Things directly from their browsers while communicating privately and securely in a decentralized way.
Information technology (IT) advances are transforming the way we innovate in business, thereby disrupting the old guard and their predictable status-quo. It’s creating global market turbulence. Industries are converging, and new opportunities and threats are emerging, like never before. So, how are savvy chief information officers (CIOs) leading this transition? Back in 2015, the IBM Institute for Business Value conducted a market study that included the findings from over 1,800 CIO interviews ...
"Matrix is an ambitious open standard and implementation that's set up to break down the fragmentation problems that exist in IP messaging and VoIP communication," explained John Woolf, Technical Evangelist at Matrix, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Web Real-Time Communication APIs have quickly revolutionized what browsers are capable of. In addition to video and audio streams, we can now bi-directionally send arbitrary data over WebRTC's PeerConnection Data Channels. With the advent of Progressive Web Apps and new hardware APIs such as WebBluetooh and WebUSB, we can finally enable users to stitch together the Internet of Things directly from their browsers while communicating privately and securely in a decentralized way.
"We host and fully manage cloud data services, whether we store, the data, move the data, or run analytics on the data," stated Kamal Shannak, Senior Development Manager, Cloud Data Services, IBM, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
While DevOps most critically and famously fosters collaboration, communication, and integration through cultural change, culture is more of an output than an input. In order to actively drive cultural evolution, organizations must make substantial organizational and process changes, and adopt new technologies, to encourage a DevOps culture. Moderated by Andi Mann, panelists discussed how to balance these three pillars of DevOps, where to focus attention (and resources), where organizations might...
Zerto exhibited at SYS-CON's 18th International Cloud Expo®, which took place at the Javits Center in New York City, NY, in June 2016. Zerto is committed to keeping enterprise and cloud IT running 24/7 by providing innovative, simple, reliable and scalable business continuity software solutions. Through the Zerto Cloud Continuity Platform™, organizations can seamlessly move and protect virtualized workloads between public, private and hybrid clouds. The company’s flagship product, Zerto Virtual...
Some people worry that OpenStack is more flash then substance; however, for many customers this could not be farther from the truth. No other technology equalizes the playing field between vendors while giving your internal teams better access than ever to infrastructure when they need it. In his session at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, will talk through some real-world OpenStack deployments and look into the ways this can benefit customers of all sizes....